Second Revision of the International Staging System (R2-ISS) for Overall Survival in Multiple Myeloma: A European Myeloma Network (EMN) Report Within the HARMONY Project

2022383 citationsJournal Articlebronze Open Access

Authors

Mattia D’Agostino · Novartis (Switzerland)

David A. Cairns · Novartis (Switzerland)

Juan José Lahuerta · Novartis (Switzerland)

Ruth Wester · Novartis (Switzerland)

Uta Bertsch · Novartis (Switzerland)

Anders Waage · Novartis (Switzerland)

Elena Zamagni ·

Abstract

The R2-ISS is a simple prognostic staging system allowing a better stratification of patients with intermediate-risk NDMM. The additive nature of this score fosters its future implementation with new prognostic variables.

Topics & Keywords

Multiple Myeloma Research and Treatments Protein Degradation and Inhibitors Peptidase Inhibition and Analysis

Publication Details

Published in: Journal of Clinical Oncology

Volume 40, Issue 29, pp. 3406-3418

DOI: 10.1200/jco.21.02614

Field-Weighted Citation Impact: 57.63

Command Palette

Second Revision of the International Staging System (R2-ISS) for Overall Survival in Multiple Myeloma: A European Myeloma Network (EMN) Report Within the HARMONY Project

Authors

Abstract

Topics & Keywords

Publication Details